Memantine has an average rating of 5.6 out of 10 from a total of 81 reviews on Drugs.com. 53% of reviewers reported a positive experience, while 33% reported a ...

Memantine has an average rating of 5.0 out of 10 from a total of 52 reviews for the treatment of Alzheimer's Disease.

Memantine is an effective pharmacotherapeutic agent, and currently the only approved option, for the treatment of moderate to severe Alzheimer's disease.

20 мар. 2019 г. · Memantine has a small beneficial effect in people with moderate‐to‐severe AD. This benefit affects thinking, the ability to carry on normal daily activities.

The results suggest that memantine may be a safe and effective therapy for patients with mild to moderate AD but further study is merited due to the conflicting ...

15 февр. 2024 г. · Considered one of the rare exceptions, memantine has consistently demonstrated restorative and prophylactic properties in many AD models.

This medication along with Aricept has been very effective. Cognitive skills, writing, alertness, sense of humor has all increased.

Pooled evidence shows that memantine compared with placebo does not significantly improve PASAT, ASS, MFIS, and EDSS scores of patients with MS. Memantine is ...

Based on the results of clinical trials, memantine has been shown to be an effective and well-tolerated treatment for moderate AD. Due to its unique mechanism ...

1 февр. 2004 г. · Memantine is a non-competitive and low–moderate-affinity NMDA antagonist, but seems to lack the CNS side effects associated with other NMDA ...